Global initiative for asthma (GINA) and its objectives (Q33940551)

30 July 2017

1 reference

title

Global initiative for asthma (GINA) and its objectives (English)

1 reference

30 July 2017

1 reference

Bousquet J

1

1 reference

30 July 2017

1 June 2000

1 reference

Clinical & Experimental Allergy

30 July 2017

1 reference

30 July 2017

30 Suppl 1

1 reference

30 July 2017

2-5

1 reference

Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines

30 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Guidelines for clinical guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Airway inflammation in mild intermittent and in persistent asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

House dust mite control measures in the management of asthma: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

House dust mite allergen avoidance in asthma. Benefits unproved but not yet excluded

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Control of house dust mite in managing asthma. Effectiveness of measures depends on stage of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

End of the New Zealand asthma mortality epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

Control of house dust mite in managing asthma. Peak expiratory flow rates in populations are not valid measure of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00088.X

10.1046/J.1365-2222.2000.00088.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10849466